Month: July 2021

Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19

Written by Customer Service on July 14, 2021. Posted in Public Companies.

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Qualigen’s QN-165 with an initial target indication for the treatment of COVID-19 in hospitalized patients. QN-165, a DNA aptamer, is a broad-based antiviral drug candidate that has exhibited antiviral activity in multiple in vitro assays against different viruses. “We are excited to have reached this important milestone of submitting our first IND application to the FDA on our most advanced therapeutics program. This submission of the IND application for Phase 1b/2a clinical trials for QN-165...

Sundt Air Proudly Adds Third Bombardier Challenger Business Jet to its Fleet

Written by Customer Service on July 14, 2021. Posted in Public Companies.

Challenger 350Sundt Air, Norway’s largest business jet operator, will offer its newest Challenger 350 business jet for charter out of Oslo, NorwayChallenger 350 aircraft boasts an unparalleled cabin, a smooth ride and the lowest direct operating costs in its category Sundt Air, Norway’s largest business jet operator, will offer its newest Challenger 350 business jet for charter out of Oslo, NorwayMONTREAL, July 14, 2021 (GLOBE NEWSWIRE) — Bombardier and Sundt Air are pleased to announce the recent delivery of a brand-new Challenger 350 business jet. Sundt Air, an executive charter, aircraft management, and special mission company based in Norway, will manage the Challenger 350 business jet out of Oslo. The aircraft will be available for charter starting in July 2021. “The Challenger 350 business jet allows passengers...

Fredonia Mining Inc. to Commence Trading With Symbol ‘FRED’

Written by Customer Service on July 14, 2021. Posted in Public Companies.

Fredonia receives the net proceeds from the $6.4 million subscription receipt financingTrading to commence July 14, 2021 with symbol FRED on the TSX Venture ExchangeTORONTO, July 14, 2021 (GLOBE NEWSWIRE) — Fredonia Mining Inc. (formerly Richmond Road Capital Corp.) (“Fredonia” or the “Company”) (TSXV: FRED) is pleased to announce that further to the press release issued on June 28, 2021 in respect of the subscription receipt financing of $6.4 million (the “Offering”), the escrow release conditions under the Offering have been satisfied and Fredonia has received approval from the TSX Venture Exchange (“TSXV”) to list its common shares on the TSXV under the symbol “FRED”, with trading to commence on Wednesday, July 14, 2021. At the request of TSXV, an additional 10,138,837 shares issued in...

VitalHub Corp. Announces Multi Year Licensing Agreement With University Hospitals Dorset NHS Foundation Trust to Support New NHS Initiative

Written by Customer Service on July 14, 2021. Posted in Public Companies.

TORONTO, July 14, 2021 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the closing of a multi-year licensing agreement with University Hospitals Dorset NHS Foundation Trust (the “Trust” or “Dorset”) in support of the initial deployment of the novel NHS “Thing Big” initiative. Through its subsidiary Intouch with Health, the Company has signed a multi-year licensing contract to support a planned multi-phase NHS initiative to disrupt patient access to elective surgery care. In response to growing wait times for elective surgery across NHS hospitals, which have been all but exacerbated by the pandemic, Dorset has commenced the “Think Big” initiative, to explore innovative ways of reducing procedure wait times, improving overall patient experience and the delivery of care. Dorset is...

People. Processes. Technology. Together. Explore IntelliChief’s Proven Playbook for Automating Accounts Payable and Order Processing With Infor

Written by Customer Service on July 14, 2021. Posted in Mergers And Acquisitions.

Join IntelliChief on July 21 for a webinar exploring strategies to help businesses improve back-office productivity and deliver better customer experiences with process automation and content management for Infor ERPs.Tampa, FL, July 14, 2021 (GLOBE NEWSWIRE) — In a post-COVID world, businesses have been forced to re-evaluate how they operate. From paying bills to processing sales orders and managing the ever-increasing inflow of documents, enterprise companies are looking for efficient and cost-effective ways to get a handle on their daily workload. The goal: simplify and automate business processes, comply with industry regulations and business rules, and streamline error-prone processes while reducing costs. With Enterprise Content Management (ECM), reaching new levels of productivity, whether remote or in-office,...

BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment

Written by Customer Service on July 14, 2021. Posted in Public Companies.

NEW YORK and VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, today announces the open recruitment and enrollment of their collaborative clinical study with Incyte. The Phase I/IIa combination study is designed to evaluate BriaCell’s lead candidate, Bria-IMT™, with Incyte’s checkpoint inhibitor, retifanlimab, and IDO1 inhibitor, epacadostat, for the treatment of advanced breast cancer. The BriaCell and Incyte clinical program is a non-exclusive clinical trial collaboration to evaluate the effects of combinations of novel clinical candidates. Under the agreement, Incyte is providing compounds from its...

Skylight Health Acquires ACO Partners and Enters Value-Based Contracting for Traditional Medicare Patients

Written by Customer Service on July 14, 2021. Posted in Mergers And Acquisitions.

TORONTO, July 14, 2021 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care group in the United States, today announced the acquisition of ACO Partners LLC (“AP”), a new Accountable Care Organization (“ACO”) that will begin participation in the Medicare Shared Savings Program (“MSSP”) offered by the Centers for Medicare and Medicaid Services (“CMS”) effective January 1, 2022.An Accountable Care Organization (“ACO”) is a healthcare organization that ties provider reimbursements to quality metrics and reductions in the cost of care. An ACO will share in the savings it achieves for the Medicare program through its MSSP participation for fee-for-service beneficiaries, and direct contracting program with CMS; Under the Medicare Shared Savings Program,...

WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.

Written by Customer Service on July 14, 2021. Posted in Mergers And Acquisitions.

On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless extraction capabilities Top-selling, award-winning brands include Color Cannabis, Saturday Cannabis, Royal City Cannabis Co., Starseed Medicinal, and U.S. licensed-brand Mary’s Medicinals Strathroy, Aylmer and Guelph sites will create synergies and further cost efficiencies bringing new strains and high-margin products to market at greater scale and consistency Entourage Health Corp. to commence trading on the TSX Venture Exchange under the ticker symbol “ENTG” effective on or about July 16, 2021TORONTO, July 14, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), a federally licensed producer and distributor of medical-grade...

Selectis Health Reports on Capital Raise, OTA, & Purchase of Non-Controlling Interest

Written by Customer Service on July 14, 2021. Posted in Public Companies.

Private Offering Greenwood Village, Colorado, July 14, 2021 (GLOBE NEWSWIRE) — Selectis Health, Inc. (f/k/a Global Healthcare REIT, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) reported completion of a $750,000 private offering through a FINRA member placement agent. The offering consisted of an aggregate of 1.5 million shares of Common Stock at a private offering price of $0.50 per share. The offering was undertaken without registration under the Securities Act of 1933 as amended (the “Act”) in reliance upon the exemption contained in Rule 506(b) of Regulation D under the Act. The Company intends to use the funds for general working capital which included the purchase of the remaining 15% minority interest in the Company’s 85% majority interest in its Goodwill Hunting, LLC facility. Additionally, funds...

Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021

Written by Customer Service on July 14, 2021. Posted in Public Companies.

ALACHUA, Fla. and TAMPA, Fla., July 14, 2021 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report second quarter 2021 financial results on Wednesday, August 4, 2021 after the market closes. Axogen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET. Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors page of the company’s website at www.axogeninc.com and clicking on the webcast link. Following...

Month: July 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals